Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 8Unknown 4Withdrawn 2Terminated 1Recruiting 1

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Conditions

Arthritis, Rheumatoid 4Spondylitis, Ankylosing 2Uveitis 1Infections 1Hematologic Neoplasms 1Cytokine Release Syndrome 1Autoimmune Diseases 1Arthritis, Juvenile 1Arthritis 1

Interventions

Infliximab 4Etanercept 4Adalimumab 3tocilizumab 1golimumab 1entecavir 1Tumor Necrosis Factor Inhibitors 1Prednisone 1Observation 1Licensure 1Leflunomide 1Glucocorticoids 1Dietary Fiber 1Antirheumatic Agents 1Anti-Inflammatory Agents, Non-Steroidal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Arthritis, Rheumatoid × Etanercept × Clear all
NCT01793519 2024-02-28

STARA

Georgetown University

Phase 4 Unknown
290 enrolled

Arthritis, Rheumatoid, Autoimmune Diseases

NCT05379049 2022-05-18

TNF-alpha

University of Sulaimani

Unknown
80 enrolled

Arthritis, Arthritis, Rheumatoid, Spondylitis, Ankylosing

NCT04115423 2020-09-10

A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab

Sungkyunkwan University

Unknown
9,508 enrolled

Arthritis, Rheumatoid, Infections

NCT02878161 2016-08-25

Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World"

Central South University

Phase 4 Unknown
240 enrolled

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡